Cite
Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study.
MLA
Katan, Mira, et al. “Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study.” PLoS ONE, vol. 9, no. 1, Jan. 2014, pp. 1–6. EBSCOhost, https://doi.org/10.1371/journal.pone.0083393.
APA
Katan, M., Moon, Y. P., Paik, M. C., Wolfert, R. L., Sacco, R. L., & Elkind, M. S. V. (2014). Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study. PLoS ONE, 9(1), 1–6. https://doi.org/10.1371/journal.pone.0083393
Chicago
Katan, Mira, Yeseon P. Moon, Myunghee C. Paik, Robert L. Wolfert, Ralph L. Sacco, and Mitchell S. V. Elkind. 2014. “Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study.” PLoS ONE 9 (1): 1–6. doi:10.1371/journal.pone.0083393.